# Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis

> **NCT01813279** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 12 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **OTHER:** the cell therapy

## Key facts

- **NCT ID:** NCT01813279
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-11
- **Final completion:** 2014-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813279, "Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01813279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*